BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10543753)

  • 1. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B; Leclercq R
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
    Wang S; Guo Y; Lv J; Qi X; Li D; Chen Z; Zhang X; Wang L; Yu F
    BMC Microbiol; 2016 Oct; 16(1):246. PubMed ID: 27769188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions.
    Isogai N; Urushibara N; Kawaguchiya M; Ghosh S; Suzaki K; Watanabe N; Quiñones D; Kobayashi N
    Microb Drug Resist; 2013 Aug; 19(4):298-307. PubMed ID: 23442208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced susceptibility to quinupristin/dalfopristin in Enterococcus faecium in Greece without prior exposure to the agent.
    Karanika M; Prati A; Kiritsi M; Spiliopoulou I; Neonakis I; Anifantaki M; Petinaki E
    Int J Antimicrob Agents; 2008 Jan; 31(1):55-7. PubMed ID: 17923393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
    Fantin B; Leclercq R; Garry L; Carbon C
    Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence.
    López F; Culebras E; Betriú C; Rodríguez-Avial I; Gómez M; Picazo JJ
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):73-7. PubMed ID: 18653303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital.
    Werner G; Klare I; Spencker FB; Witte W
    J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in Western Europe.
    Soltani M; Beighton D; Philpott-Howard J; Woodford N
    Antimicrob Agents Chemother; 2000 Feb; 44(2):433-6. PubMed ID: 10639378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands.
    Jensen LB; Hammerum AM; Aerestrup FM; van den Bogaard AE; Stobberingh EE
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3330-1. PubMed ID: 10049241
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany.
    Werner G; Klare I; Heier H; Hinz KH; Böhme G; Wendt M; Witte W
    Microb Drug Resist; 2000; 6(1):37-47. PubMed ID: 10868806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
    Matsumura SO; Louie L; Louie M; Simor AE
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.
    McDonald LC; Rossiter S; Mackinson C; Wang YY; Johnson S; Sullivan M; Sokolow R; DeBess E; Gilbert L; Benson JA; Hill B; Angulo FJ
    N Engl J Med; 2001 Oct; 345(16):1155-60. PubMed ID: 11642231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
    Kang SL; Rybak MJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
    Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
    Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing.
    Jamjian C; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):129-38. PubMed ID: 9154409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium.
    Bonilla HF; Perri MB; Kauffman CA; Zervos MJ
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):127-31. PubMed ID: 8902408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of streptogramin growth promoters in poultry and isolation of streptogramin-resistant Enterococcus faecium from humans.
    Kieke AL; Borchardt MA; Kieke BA; Spencer SK; Vandermause MF; Smith KE; Jawahir SL; Belongia EA;
    J Infect Dis; 2006 Nov; 194(9):1200-8. PubMed ID: 17041845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
    Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
    J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals.
    Hammerum AM; Jensen LB; Aarestrup FM
    FEMS Microbiol Lett; 1998 Nov; 168(1):145-51. PubMed ID: 9812375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.